Showing results (901-910 of 1,032) with videos related to
Sort By:
Pageof 104
Biomarker Research|August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG reportEra L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface MalignanciesVarun V Bansal, Elizabeth L Godfrey, Javid Sadjadi, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 12, 2018
[Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]L Wei, J Cheng, J Luo, et al.Nature Cardiovascular Research|May 18, 2026
Single-cell and spatial transcriptomics identify immune-stromal interactions in cardiac allograft vasculopathyMacee C Owen, Daniel Yuhang Li, Haewon Shin, et al.Blood|April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionCarla S Wilson, George S Davidson, Shawn B Martin, et al.Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|June 2, 2006
Cancer consequences of the Chernobyl accident: 20 years onElisabeth Cardis, Geoffrey Howe, Elaine Ron, et al.Clinical and Experimental Medicine|November 2, 2023
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 studyMatteo Santoni, Francesco Massari, Hideki Takeshita, et al.Frontiers in Immunology|May 6, 2026
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1)Evelyn L Beas-Lozano, Sarah Scagliarini, Paola I Valdez-Sandoval, et al.Journal of Critical Care|October 11, 2022
The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradoxM Balik, E Svobodova, M Porizka, et al.Neurology. Genetics|December 12, 2018
TPP2 mutation associated with sterile brain inflammation mimicking MSEva M Reinthaler, Elisabeth Graf, Tobias Zrzavy, et al.Pageof 104